Cerep offers in vitro pharmacology, in vitro ADME-Tox and in vivo PK services, and provides solutions allowing faster and cost-effective drug discovery by identifying at early stages the most promising drug candidates as well as eliminating those compounds likely to fail in development. Cerep’s services benefit annually to about 500 pharmaceutical and biotechnological companies worldwide including most of the top pharmaceutical firms.
Celle-Lévescault, FR
178 (est)
Eurofins-Cerep is headquartered in Celle-Lévescault, FR

Eurofins-Cerep Locations

Celle-Lévescault, FR
Saint Charles, US
Dundee Technology Park, GB

Eurofins-Cerep Metrics

Eurofins-Cerep Summary

Market capitalization

€24.2 M

Closing share price

Eurofins-Cerep's current market capitalization is €24.2 M.

Eurofins-Cerep Market Value History

Eurofins-Cerep Company Life